🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing
Updated 06 Sep 2026 · ClinicalTrials.gov

Clinical Trials in Manchester

← All UK trials

The most recently updated industry-sponsored clinical trials recruiting across the United Kingdom — searchable by condition, sponsor, phase and city. Refreshed daily from the ClinicalTrials.gov registry.

28
Recruiting now
38
Studies tracked
Manchester
Selected city
Active Phase 2
Solid Tumors
Hoffmann-La Roche · started 2021-01-18
Glasgow · London · Manchester
NCT04589845 on ClinicalTrials.gov ↗
Recruiting Phase 4
Breast Cancer
Hoffmann-La Roche · started 2024-04-02
Basingstoke · London · Manchester
NCT06274515 on ClinicalTrials.gov ↗
Recruiting Phase 1
Ovarian Cancer, Squamous Non-Small Cell Lung Cancer (NSCLC), Synovial Sarcomas, Head and Neck Cancer
Zelluna Immunotherapy AS · started 2026-05-11
London · Manchester
NCT07613723 on ClinicalTrials.gov ↗
Recruiting Phase 3
Alcohol Use Disorder
Eli Lilly and Company · started 2025-10-15
Blackpool · Chester · Eastbourne · Edinburgh · Glasgow
NCT07219966 on ClinicalTrials.gov ↗
Recruiting Phase 1
Advanced/Metastatic Solid Tumors, Bladder Cancer, Urothelial Carcinoma, Advanced Non-Small Cell Lung Cancer
Pfizer · started 2025-08-20
London · Manchester
NCT07090499 on ClinicalTrials.gov ↗
Recruiting Phase 2
Opioid Use Disorder
Eli Lilly and Company · started 2026-02-13
Chertsey · Doncaster · Eastbourne · Glasgow · London
NCT07420283 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Solid Tumors
ORIC Pharmaceuticals · started 2022-03-10
Manchester
NCT05315700 on ClinicalTrials.gov ↗
Active Phase 2
ANCA Associated Vasculitis (AAV)
Novartis Pharmaceuticals · started 2025-03-13
Cambridge · Glasgow · London · Manchester
NCT06868290 on ClinicalTrials.gov ↗
Active Phase 2/Phase 3
Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
Biogen · started 2022-09-13
London · Manchester · Birmingham · Leeds
NCT05531565 on ClinicalTrials.gov ↗
Active Phase 3
Generalized Anxiety Disorder
Definium Therapeutics US, Inc. · started 2025-01-29
Glasgow · Gosforth · London · Manchester · Sheffield
NCT06809595 on ClinicalTrials.gov ↗
Recruiting Phase 1
Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
Eli Lilly and Company · started 2024-07-01
London · Manchester
NCT06465069 on ClinicalTrials.gov ↗
Recruiting Phase 3
Non-small Cell Lung Cancer
Boehringer Ingelheim · started 2026-01-16
Cardiff · Edinburgh · London · Manchester · Sutton
NCT07195695 on ClinicalTrials.gov ↗
Recruiting Phase 3
PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Breast Cancer
Relay Therapeutics, Inc. · started 2025-08-26
Bath · Cardiff · London · Manchester · Swindon
NCT06982521 on ClinicalTrials.gov ↗
Starting soon Phase 1
COPD (Chronic Obstructive Pulmonary Disease)
AeroRx Therapeutics Inc. · started 2026-09
Manchester
NCT07802730 on ClinicalTrials.gov ↗
Recruiting Phase 3
Lymphoma
Hoffmann-La Roche · started 2023-10-22
Glasgow · Lincoln · London · Manchester · Oxford
NCT06084936 on ClinicalTrials.gov ↗
Recruiting Phase 3
Prostate Cancer Metastatic
Merck Sharp & Dohme LLC · started 2023-12-31
Cambridge · Truro · Glasgow · London · Manchester
NCT06136624 on ClinicalTrials.gov ↗
Recruiting Phase 2
Advanced Breast Cancer
AstraZeneca · started 2026-05-06
Cambridge · London · Manchester
NCT07427394 on ClinicalTrials.gov ↗
Starting soon Phase 3
Interstitial Lung Diseases
Boehringer Ingelheim · started 2026-09-14
Birmingham · Exeter · Leeds · Leicester · London
NCT07540988 on ClinicalTrials.gov ↗
Recruiting Phase 2
FGFR2 Gene Fusion/Rearrangement, Other Solid Tumors, Adult
Elevar Therapeutics · started 2026-06-04
London · Manchester
NCT07359820 on ClinicalTrials.gov ↗
Recruiting Phase 3
Ovarian Neoplasms, Ovarian Cancer
Merck Sharp & Dohme LLC · started 2026-02-16
Cambridge · Leicester · London · Manchester
NCT07318558 on ClinicalTrials.gov ↗
Recruiting Phase 3
Hepatocellular Carcinoma
AstraZeneca · started 2025-05-06
Cambridge · Leeds · London · Manchester
NCT06921785 on ClinicalTrials.gov ↗
Recruiting Phase 3
Solid Tumors, Hematologic Malignancies
Merck Sharp & Dohme LLC · started 2018-08-21
Aberdeen · Cambridge · Edinburgh · Manchester · Sheffield
NCT03486873 on ClinicalTrials.gov ↗
Recruiting Phase 3
Locally Advanced Head and Neck Squamous Cell Carcinoma
AstraZeneca · started 2023-12-14
Aberdeen · Cambridge · Hampshire · Leeds · London
NCT06129864 on ClinicalTrials.gov ↗
Active Phase 3
Non-Small Cell Lung Cancer
AstraZeneca · started 2019-07-02
Cambridge · Leicester · Liverpool · Maidstone · Manchester
NCT04035486 on ClinicalTrials.gov ↗
Recruiting Phase 3
Von Hippel-Lindau Disease, Malignant Neoplasms
Merck Sharp & Dohme LLC · started 2026-03-23
Glasgow · London · Manchester
NCT07405164 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Solid Malignancies
Carrick Therapeutics Limited · started 2024-08-16
Manchester · Oxford · Sutton
NCT06600789 on ClinicalTrials.gov ↗
Recruiting
Geographic Atrophy Secondary to Age-related Macular Degeneration
Complement Therapeutics · started 2025-07-30
Gloucester · London · Southampton · Sunderland · Belfast
NCT07144137 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
Merck Sharp & Dohme LLC · started 2026-05-03
Plymouth · Manchester
NCT07519772 on ClinicalTrials.gov ↗
Active Phase 3
Metastatic Pancreatic Ductal Adenocarcinoma
Arcus Biosciences, Inc. · started 2024-12-13
Birmingham · Cottingham · London · Manchester
NCT06608927 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Renal Cell Carcinoma
Merck Sharp & Dohme LLC · started 2025-07-20
Edinburgh · Glasgow · London · Cardiff · Manchester
NCT07049926 on ClinicalTrials.gov ↗
Recruiting Phase 3
Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc. · started 2025-12-11
Cardiff · London · Manchester · Sheffield
NCT07144163 on ClinicalTrials.gov ↗
Recruiting Phase 2
Solid Tumours
Boehringer Ingelheim · started 2024-10-11
Dundee · London · Manchester
NCT06581432 on ClinicalTrials.gov ↗
No trials match your search.

Browse by city

London · 112 Manchester · 38 Cambridge · 28 Glasgow · 27 Birmingham · 27 Oxford · 23 Leicester · 20 Bristol · 20 Leeds · 16 Cardiff · 16 Liverpool · 15 Edinburgh · 13 Sheffield · 13 Sutton · 13 Newcastle upon Tyne · 12 Exeter · 12

Browse by condition

Obesity · 5 Breast Cancer · 5 Solid Tumors · 4 Overweight · 4 Non-small Cell Lung Cancer · 3 Ovarian Cancer · 3 Prostate Cancer · 3 Cardiovascular Diseases · 3 Bladder Cancer · 2 Diabetes Mellitus, Type 1 · 2 Chronic Migraine · 2 Systemic Lupus Erythematosus · 2 Non-small Cell Lung Cancer (NSCLC) · 2 Hypertension · 2 Systemic Lupus Erythematosus (SLE) · 2 Ulcerative Colitis · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the UK Tracker. Available at: https://priyalifescience.com/clinical-trials-uk/city/manchester (Accessed: 6 September 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one UK site, most recently updated first, refreshed daily. This is a curated slice of the registry, not every UK trial; UK studies may also be registered on ISRCTN. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our UK Pharma Salary Guide, or see our Ireland, EU and USA trackers.